Mantara Health

Mantara Health Knowledge is the best medicine ™

🧬 An 88-year-old had a stroke in Glasgow. A cheek swab changed his medication.He's one of more than 2,000 NHS patients n...
06/08/2026

🧬 An 88-year-old had a stroke in Glasgow. A cheek swab changed his medication.

He's one of more than 2,000 NHS patients now taking part in the PHOENIX trial, which is testing whether PGx results can help clinicians prescribe more accurately from the start.

📩 To find out how Mantara's PGx Panel could support your patients or practice, send us a DM or email [email protected].

04/08/2026

🩺 A colleague mentioned something .mark.martin hadn't considered: some patients on clopidogrel after a stroke might not be getting the protection it's meant to provide.

Around 30% of patients prescribed clopidogrel for stroke prevention can't metabolise the drug effectively, due to how their genes affect its activation in the body.

That's what led him to pharmacogenomics.

The evidence for Pharmacogenomic (PGx) testing continues to grow.A recent real-world study found that multi-gene PGx tes...
30/07/2026

The evidence for Pharmacogenomic (PGx) testing continues to grow.

A recent real-world study found that multi-gene PGx testing identified actionable results for many patients taking commonly prescribed medications and was associated with a trend towards lower healthcare costs. As more evidence emerges, PGx is becoming an increasingly valuable tool in supporting more personalised prescribing.

📩 To find out how Mantara's PGx Panel could support your patients or clinical practice, send us a DM or email [email protected].

Reference: El Rouby N et al. Clinical and Translational Science. 2025;18:e70418.

28/07/2026

Side effects aren't always just about the medication you're taking. They can also be influenced by your genetics.

The way your body processes certain medicines varies from person to person. Some people break down medications too quickly, others too slowly, which can affect both how well they work and the likelihood of experiencing side effects.

Pharmacogenomic (PGx) testing helps clinicians understand these genetic differences, supporting more personalised prescribing decisions.

📩 To find out how Mantara's PGx Panel could support your patients or clinical practice, send us a DM or email [email protected].

New research published in The Pharmacogenomics Journal found that patients with certain CYP2C19 and CYP2D6 genetic varia...
23/07/2026

New research published in The Pharmacogenomics Journal found that patients with certain CYP2C19 and CYP2D6 genetic variants were more likely to discontinue specific antidepressants, including escitalopram, sertraline and venlafaxine.

These findings add to the growing body of evidence supporting the role of Pharmacogenomic (PGx) testing in personalised prescribing.

📩 To learn more about Mantara's PGx Panel, send us a DM or email [email protected].

21/07/2026

The future of medicine isn't one-size-fits-all. It's personalised.

Pharmacogenomic (PGx) testing helps clinicians understand how a patient's genetics may influence their response to medication, supporting more informed prescribing decisions and helping to reduce trial and error.

As the evidence continues to grow, we believe PGx will become an integral part of routine clinical care.

📩 To find out how Mantara's PGx Panel could support your patients or practice, send us a DM or email [email protected].

We love hearing stories like this.Michael took our PGx Panel to better understand how his genetics could influence his r...
16/07/2026

We love hearing stories like this.

Michael took our PGx Panel to better understand how his genetics could influence his response to medication. What he discovered not only gave him reassurance about his own treatment, but also prompted him to arrange testing for his dad following a previous stroke.

Thank you, Michael, for sharing your story. We're looking forward to helping your dad too.

If you'd like to learn more about Pharmacogenomic (PGx) testing, send us a DM or email [email protected].

14/07/2026

The medication you're taking could be less effective than you think.

Your genes can influence how your body processes many commonly prescribed medications. For example, around 1 in 3 people have a CYP2C19 gene variant that can reduce the effectiveness of Clopidogrel. The same principle applies to many antidepressants, pain medications, statins and more.

If you'd like to find out whether the medications you're taking are the best fit for your genetics, email [[email protected]](mailto:[email protected]) to learn more about Pharmacogenomic (PGx) testing.

The evidence for Pharmacogenomic (PGx) testing continues to grow.A recent study found that patients with major depressiv...
10/07/2026

The evidence for Pharmacogenomic (PGx) testing continues to grow.

A recent study found that patients with major depressive disorder who received PGx-guided prescribing were more likely to achieve remission and respond to treatment, with benefits that persisted over time.

As we move towards more personalised medicine, PGx has the potential to help clinicians make more informed prescribing decisions and improve patient outcomes.

📩 To find out how PGx testing could support your patients or clinical practice, send us a DM or email [email protected].

09/07/2026

NICE now recommends CYP2C19 testing before prescribing Clopidogrel after an ischaemic stroke or TIA. Yet for many people, this still isn't routine practice.

As a result, around 1 in 3 people may have a CYP2C19 gene variant that affects how well they metabolise Clopidogrel, without realising they may not be getting the protection they expect.

If you'd like to find out more about Pharmacogenomic (PGx) testing, email [email protected] or DM us.

Address

London

Website

Alerts

Be the first to know and let us send you an email when Mantara Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Mantara Health:

Shortcuts

Featured

Share

Category